Spanish private equity fund Nzyme, backed by Kibo Ventures, raises €160 million to invest in Spanish companies in B2B sectors with a focus on digital transformation and consolidation.
Nzyme attracted diverse investors including CDTI, Spanish business families, successful entrepreneurs, banks, and international family offices.
The fund aims to create industry leaders by combining consolidation with technological innovation and has a team of professionals with experience in private equity, technology, and business transformation.
Nzyme's strategy involves investing in service and software companies within fragmented industries, aiming to create strong leaders through consolidation, technological innovation, and advanced technologies.